Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://dx.doi.org/10.25673/32854
Titel: Interaction of Purinergic P2X4 and P2X7 Receptor Subunits
Autor(en): Schneider, Markus
Prudic, Kirsten
Klapperstück, Manuela
Braam, Ursula
Müller, Christa
Schmalzing, Günther
Markwardt, Fritz
Erscheinungsdatum: 2017-11-22
Art: Artikel
Sprache: Englisch
Herausgeber: Universitäts- und Landesbibliothek Sachsen-Anhalt
Schlagwörter: P2X4
P2X7
voltage clamp
fluorescence
FRET
interaction
subunit
Zusammenfassung: P2X4 and P2X7 are members of the P2X receptor family, comprising seven isoforms (P2X1–P2X7) that form homo- and heterotrimeric non-specific cation channels gated by extracellular ATP. P2X4 and P2X7 are widely coexpressed, particularly in secretory epithelial cells and immune and inflammatory cells, and regulate inflammation and nociception. Although functional heteromerization has been established for P2X2 and P2X3 subunits expressed in sensory neurons, there are contradictory reports regarding a functional interaction between P2X4 and P2X7 subunits. To resolve this issue, we coexpressed P2X4 and P2X7 receptor subunits labeled with green (EGFP) and red (TagRFP) fluorescent proteins in Xenopus laevis oocytes and investigated a putative physical interaction between the fusion proteins by Förster resonance energy transfer (FRET). Coexpression of P2X4 and P2X7 subunits with EGFP and TagRFP located in the extracellular receptor domains led to significant FRET signals. Significant FRET signals were also measured between C-terminally fluorophore-labeled full-length P2X41-384 and C-terminally truncated fluorescent P2X71-408 subunits. We furthermore used the two-electrode voltage clamp technique to investigate whether human P2X4 and P2X7 receptors (hP2X4, hP2X7) functionally interact at the level of ATP-induced whole-cell currents. Concentration–response curves and effects of ivermectin (P2X4-potentiating drug) or BzATP (P2X7-specific agonist) were consistent with a model in which coexpressed hP2X4 and hP2X7 do not interact. Similarly, the effect of adding specific inhibitors of P2X4 (PSB-15417) or P2X7 (oATP, A438079) could be explained by a model in which only homomers exist, and that these are blocked by the respective antagonist. In conclusion, we show that P2X4 and P2X7 subunits can form heterotrimeric P2X4/P2X7 receptors. However, unlike observations for P2X2 and P2X3, coexpression of P2X4 and P2X7 subunits does not result in a novel electrophysiologically discriminable P2X receptor phenotype.
URI: https://opendata.uni-halle.de//handle/1981185920/33045
https://lhhal.gbv.de/DB=10/XMLPRS=N/PPN?PPN=1047296373
http://dx.doi.org/10.25673/32854
Open-Access: Open-Access-Publikation
Nutzungslizenz: (CC BY 4.0) Creative Commons Namensnennung 4.0 International(CC BY 4.0) Creative Commons Namensnennung 4.0 International
Sponsor/Geldgeber: DFG Ma1581/15– 3
DFG Schm536/9–3
Journal Titel: Frontiers in Pharmacology
Band: 8
Originalveröffentlichung: 10.3389/fphar.2017.00860
Seitenanfang: 860
Enthalten in den Sammlungen:Medizinische Fakultät MLU

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
fphar-08-00860_mlu.pdf6.41 MBAdobe PDFMiniaturbild
Öffnen/Anzeigen